Molecular Diagnostics

A Short Explanation

We use molecular diagnostics to analyze biological markers in the genome and proteome. We look at how their cells express their genes as proteins in order to improve the medical diagnosis with possible implications for targeted treatment.

Martin Luzbetak

MUDr. Lužbeták

MUDr. Lužbeták started his medical journey at Jessenius Faculty of Medicine in Martin (Comenius University in Bratislava) studying general medicine. He continued at Dresden International University, where he studied preventive medicine and graduated with a M.Sc. degree in 2016. MUDr. Lužbeták is engaged in scientific activities and presents results at international scientific forums. He works with leading experts and clinics from around the world. MUDr. Lužbeták is most pleased with the patient’s smile after successful treatment and when they can return to living life to the fullest. 

MUDr. Lužbeták ‘s is part of the NextGen Oncology Group whose purpose is to develop patient-focused, personalized diagnostics & advanced therapies for patients and the doctors who treat them and to find new hope through science-based approaches.

Every patient is unique, every tumor is unique and deploys its own set of complex molecular interactions. There is still an unmet need for personalized diagnostics to inform clinicians on the best treatment options. Companion diagnostics have the extraordinary power to connect a patient’s unique genetic profile to targeted, personalized treatment options. NextGen delivers cancer diagnostics insights that provide doctors with precision treatment strategies that can provide better care to patients.

MUDr. Lužbeták Professional Credentials

Professional Title

Approbation as physician (government Upper Bavaria) 2010

Medicinae universae doctor (JLF UK Martin) 2010

Master of Science in Preventive Medicine (DIU Dresden) 2016

Board certified general physician (BLAEK München) 2018

Master in molecular oncology (CEB Madrid) 2021

Supervisory Authority:

Ärztekammer Nordrhein

Tersteegenstr. 9 · 40474 Düsseldorf

Tel. 0211 / 4302-0 · Fax 0211 / 4302 2009


The following professional regulations apply: Professional regulations for German physicians

Regulations can be viewed at:


About us

The ATGesundheit Institute website presents information about oncolytic virus (OV) cancer immunotherapy for glioblastoma multiforme (GBM), solid tumors and breast cancer. Our website is dedicated to exploring the therapeutic potential of OVs for incurable tumors and the therapeutic mechanisms of various OVs.

Contact US

Scroll to Top
Skip to content